Financial publications

Marinomed Biotech AG
Investors & ESG
Financial publications

ALL
2022
2021
2020
2019
2018
2017

(2 MB)

(4 MB)

(2 MB)

(1 MB)

(2 MB)

(47 KB)

(70 KB)

(67 KB)

(2 MB)

(944 KB)

(2 MB)

(1 MB)

(176 KB)

(385 KB)

(168 KB)

(4 MB)

(2 MB)

(960 KB)

(1 MB)

(140 KB)

(138 KB)

(127 KB)

(47 KB)

Bericht des Vorstands der Marinomed Biotech AG FN 276819 m, ISIN ATMARINOMED6 gemäß § 174 Abs 4 iVm § 153 Abs 4, § 171 Abs 1 AktG (German Only)

(106 KB)

(938 KB)

(248 KB)

(837 KB)

(178 KB)

(329 KB)

(141 KB)

(1 MB)

(584 KB)

(345 KB)

(918 KB)

(574 KB)

(132 KB)

(61 KB)

(59 KB)

Veröffentlichung gemäß § 5 Abs. 2 Rechnungslegungs-Kontrollgesetz (RL-KG) vom 04.09.2020 (German only)

(25 KB)

(1 MB)

(2 MB)

(678 KB)

(1 MB)

(845 KB)

(690 KB)

(965 KB)

(676 KB)

(999 KB)

(2 MB)

(3 MB)

(832 KB)

(2 MB)

Stephanie Kniep, Dipl.-Ök.

Head of Investor Relations

+ 43 2262 90300 ir@marinomed.com

Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg, Austria
+43 2262 90300
office@marinomed.com